3 ms·
SSRIs, and anti-depressants in general, are subject to an unavoidable failure mode of evidence-based medicine's "gold standard", randomly-controlled trials (RCT
by ncmncm 5y ago
SSRIs, and anti-depressants in general, are subject to an unavoidable failure mode of evidence-based medicine's "gold standard", randomly-controlled trials (RCT): ambiguous diagnosis.
If you are unable to distinguish between a half-dozen causes for what appears to be the same illness, your RCT of even a perfect cure (for one of the causes) will show arbitrarily small positive effects, and possibly large negative effects, according to the prevalence of each actual cause represented in the sample population.
Thus, we see assertions in scurrilous publications that "anti-depressants don't work any better than placebo", despite that they make the difference for millions of real patients between 100% dysfunction and normal life. Psychiatrists are stuck with no better means to diagnose the different kinds of depression than to prescribe different anti-depressants, one after another, and see which, if any, help.
It is almost miraculous that the anti-depressants we have were approved. It is doubtful they would be approved today. That is a consequence of fetishizing RCTs as "the gold standard" to imply that no further thought is needed in evaluating its results.
The world economy has abandoned the actual gold standard, for reasons.
... But, yes, to your point, there are certain ad-hoc routes by which evidence can sometimes get through to medical practice despite typical epistemological roadblocks.